Medical Marijuana, Inc. and its subsidiary Kannalife™ Sciences received attention in a major media outlet this week when Medical Marijuana, Inc. CEO Dr. Stuart Titus and Kannalife™ Sciences’s Thoma Kikis were interviewed for Fox News Radio.
Listen to the interview below:
The first questions were directed at Mr. Kikis, who discussed the process of getting the first licenses awarded to develop medications under the government’s patent 6,630,507, “Cannabinoids as antioxidants and neuroprotectants.”
Kannalife™ Sciences is creating intellectual property surrounding cannabinoids through the development of treatments that fall under the orphan drug designation, allowing them to speed through the new drug approval process.
Following Mr. Kikis, Dr. Titus took time to discuss the science behind cannabinoids as pertaining to the work being done at Kannalife™ Sciences before detailing the delivery systems of a number of products in the Medical Marijuana, Inc. portfolio of brands.
The interview ended with discussion of Medical Marijuana, Inc.’s movement into the Latin American marketplace, with Dr. Titus detailing our expansion efforts in the region.
Coverage by popular national news outlets like Fox News help to normalize the use of cannabis both as a prescription medication and as a dietary supplement in the U.S. and validates the important work being done by Medical Marijuana, Inc.’s portfolio of companies.
